You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Effect of cyclo-oxygenase inhibitor use during checkpoint blockade immunotherapy in patients with metastatic melanoma and non-small cell lung cancer

Article metrics

Article menu

Download PDFPDF

XML
Clinical/translational cancer immunotherapy
Original research
Effect of cyclo-oxygenase inhibitor use during checkpoint blockade immunotherapy in patients with metastatic melanoma and non-small cell lung cancer

 

Online download statistics by month:

Online download statistics by month: October 2020 to March 2024

AbstractFullPdf
Oct 2020552552180
Nov 202019819763
Dec 2020949425
Jan 2021999920
Feb 202121721719
Mar 2021858528
Apr 2021515126
May 2021262623
Jun 2021434318
Jul 2021515123
Aug 2021484820
Sep 2021626217
Oct 2021424230
Nov 2021697132
Dec 2021494921
Jan 2022485121
Feb 2022333417
Mar 2022434426
Apr 2022505114
May 2022636452
Jun 2022646617
Jul 2022505018
Aug 2022545421
Sep 2022545522
Oct 2022485022
Nov 2022535320
Dec 2022474914
Jan 202335358
Feb 2023989820
Mar 2023525325
Apr 2023212322
May 202328287
Jun 2023414220
Jul 2023353722
Aug 202325278
Sep 202314146
Oct 2023242412
Nov 2023505017
Dec 2023222211
Jan 202421228
Feb 2024394127
Mar 2024363617
Total283428601039